Literature DB >> 18434905

The lectin-like domain of tumor necrosis factor-alpha improves alveolar fluid balance in injured isolated rabbit lungs.

István Vadász1, Ralph T Schermuly, Hossein A Ghofrani, Sebastian Rummel, Susan Wehner, Inge Mühldorfer, Klaus P Schäfer, Werner Seeger, Rory E Morty, Friedrich Grimminger, Norbert Weissmann.   

Abstract

OBJECTIVE: Identification of mechanisms that preserve optimal alveolar fluid balance during pulmonary edema is of great clinical importance. This study was performed to determine whether the lectin-like domain of tumor necrosis factor-alpha (designated TIP) can improve fluid balance in experimental lung injury by affecting alveolocapillary permeability and/or fluid clearance.
DESIGN: Prospective, randomized laboratory investigation.
SETTING: University-affiliated laboratory.
SUBJECTS: Adult male rabbits.
INTERVENTIONS: TIP, a scrambled peptide (scrTIP), dibutyryl cyclic adenosine monophosphate (db-cAMP), or saline was applied to isolated, ventilated, and buffer-perfused rabbit lungs by ultrasonic nebulization, after which hydrostatic edema or endo/exotoxin-induced lung injury was induced and edema formation was assessed. In studies evaluating the resolution of alveolar edema, 2.5 mL of excess fluid was deposited into the alveolar space of isolated lungs by nebulization in the absence or presence of TIP, scrTIP, amiloride, or ouabain or combinations thereof.
MEASUREMENTS AND MAIN RESULTS: Microvascular permeability was largely increased during hydrostatic edema and endo/exotoxin-induced lung injury in saline-treated lungs, or lungs that received scrTIP, as assessed by capillary filtration coefficient (K(f,c)) and fluorescein isothiocyanate-labeled albumin flux across the alveolocapillary barrier. In contrast, TIP- or db-cAMP-treated lungs exhibited significantly lower vascular permeability upon hydrostatic challenge. Similarly, extravascular fluid accumulation, as assessed by fluid retention, wet weight to dry weight ratio, and epithelial lining fluid volume measurements, was largely inhibited by TIP or db-cAMP pretreatment. Furthermore, TIP increased sodium-potassium adenosine triphosphatase (Na,K-ATPase) activity 1.6-fold by promoting Na,K-ATPase exocytosis to the alveolar epithelial cell surface and increased amiloride-sensitive sodium uptake, resulting in a 2.2-fold increase in active Na+ transport, and hence improved clearance of excess fluid from the alveolar space.
CONCLUSIONS: Aerosolized TIP improved alveolar fluid balance by both reducing vascular permeability and enhancing the absorption of excess alveolar fluid in experimental lung injury. These data may suggest a role for TIP as a potential therapeutic agent in pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434905     DOI: 10.1097/CCM.0b013e31816f485e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  29 in total

1.  Essential structural features of TNF-α lectin-like domain derived peptides for activation of amiloride-sensitive sodium current in A549 cells.

Authors:  Parastoo Hazemi; Susan J Tzotzos; Bernhard Fischer; Gowri Shankar Bagavananthem Andavan; Hendrik Fischer; Helmut Pietschmann; Rudolf Lucas; Rosa Lemmens-Gruber
Journal:  J Med Chem       Date:  2010-10-27       Impact factor: 7.446

Review 2.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

3.  Novel molecular strategy to prevent pulmonary edema.

Authors:  Michael A Matthay; Yves Berthiaume
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

4.  A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation.

Authors:  István Czikora; Abdel Alli; Hui-Fang Bao; David Kaftan; Supriya Sridhar; Hans-Jürgen Apell; Boris Gorshkov; Richard White; Astrid Zimmermann; Albrecht Wendel; Meike Pauly-Evers; Jürg Hamacher; Irène Garcia-Gabay; Bernhard Fischer; Alexander Verin; Zsolt Bagi; Jean Francois Pittet; Waheed Shabbir; Rosa Lemmens-Gruber; Trinad Chakraborty; Ahmed Lazrak; Michael A Matthay; Douglas C Eaton; Rudolf Lucas
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

Review 5.  Ion channels in inflammation.

Authors:  Michael Eisenhut; Helen Wallace
Journal:  Pflugers Arch       Date:  2011-01-29       Impact factor: 3.657

Review 6.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 7.  Ubiquitination and proteolysis in acute lung injury.

Authors:  István Vadász; Curtis H Weiss; Jacob I Sznajder
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

8.  Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs.

Authors:  Yasmin Buchäckert; Sebastian Rummel; Christine U Vohwinkel; Nieves M Gabrielli; Benno A Grzesik; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  J Physiol       Date:  2012-07-23       Impact factor: 5.182

9.  The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation--potential role for a reduction in reactive oxygen species generation.

Authors:  Jürg Hamacher; Uz Stammberger; Jeremie Roux; Sanjiv Kumar; Guang Yang; Chenling Xiong; Ralph A Schmid; Richard M Fakin; Trinad Chakraborty; Hamid M D Hossain; Jean-François Pittet; Albrecht Wendel; Stephen M Black; Rudolf Lucas
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

10.  AP301, a synthetic peptide mimicking the lectin-like domain of TNF, enhances amiloride-sensitive Na(+) current in primary dog, pig and rat alveolar type II cells.

Authors:  Susan Tzotzos; Bernhard Fischer; Hendrik Fischer; Helmut Pietschmann; Rudolf Lucas; Gilles Dupré; Rosa Lemmens-Gruber; Parastoo Hazemi; Victoria Prymaka; Waheed Shabbir
Journal:  Pulm Pharmacol Ther       Date:  2013-01-09       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.